Immunization News and Research

RSS

Fusion proteins enable the creation of monoclonal antibodies

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to advance research projects.

26 Mar 2025

COVID-19 vaccines may cut risk of long COVID

Full COVID-19 vaccination may reduce post-COVID-19 condition risk by 27%, though more research is needed, especially for children and immunocompromised groups.

26 Mar 2025

Report shows alarming measles resurgence in Europe and US

A recent report shows cases of measles across the World Health Organization's European Region, which includes the UK, are the highest they've been for more than 25 years. At the same time, large outbreaks of measles in the US have led to the first measles deaths there since 2015.

26 Mar 2025

Study reveals how B cells safeguard high-affinity antibodies

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating in hopes of generating the most effective antibodies.

19 Mar 2025

Groundbreaking vaccine study offers hope for ending meningitis in Africa

University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and effective for use in young children beginning at 9 months of age.

11 Mar 2025

Canary in the coalmine: Study warns 21 million children missed measles shots in 2022

Researchers found that 21 million children missed measles vaccination in 2022, far exceeding those missing other vaccines, and 96% were in low- and middle-income countries. The study urges adding measles vaccination rates to global definitions of under-immunized children to better prevent deadly outbreaks.

10 Mar 2025

How falling measles vaccination rates put millions of children at risk

Two-dose measles vaccination coverage has fallen by 3.7% globally since 2019, leaving most WHO regions off track to meet Immunization Agenda 2030 targets. The study highlights a worrying rise in zero-dose children, especially in Africa, threatening global herd immunity against measles.

10 Mar 2025

MRNA vaccines, once a Trump boast, now face attacks from some in GOP

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

10 Mar 2025

Study suggests boosting brain's immune cells could improve Alzheimer's treatment

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques - sticky clumps of toxic protein that accumulate in the brain.

6 Mar 2025

WHO Director-General issues revised recommendations on mpox emergency

The Director-General of the World Health Organization (WHO), following the third meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the upsurge of mpox 2024, held on 25 February 2025, from 12:00 to 17:00 CET, concurs with its advice that the event continues to meet the criteria of a public health emergency of international concern and, considering the advice of the Committee, he is hereby issuing a revised set of temporary recommendations.

27 Feb 2025

Why over 5 billion people still lack access to life-saving medical oxygen

The Lancet Global Health Commission highlights severe inequities in medical oxygen access, urging systemic reforms to ensure universal availability and affordability.

23 Feb 2025

Texas measles outbreak nears 100 cases, raising concerns about undetected spread

Some private schools have shut down because of a rapidly escalating measles outbreak in West Texas. Local health departments are overstretched, pausing other important work as they race to limit the spread of this highly contagious virus.

21 Feb 2025

Leinco Technologies awarded $1M grant to develop rapid test for intestinal immunity to polio

Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1 M grant from the Gates Foundation.

From Leinco Technologies 14 Feb 2025

The growing list of human viruses: Are we prepared for the next outbreak?

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent need for prevention and global surveillance.

12 Feb 2025

Groundbreaking malaria vaccine provides high-level protection with just one dose

Scientists at Sanaria and Seattle Children's Research Institute's Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, designed to provide high-level protection with just one dose.

12 Feb 2025